◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Lifeist Wellness Inc.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q3 2025Aug 31, 2025 Q2 2025May 31, 2025 Q1 2025Feb 28, 2025 Q4 2024Nov 30, 2024 Q3 2024Aug 31, 2024
Total Revenue 32,755 64,689 73,633 -9.6M 130,051
Operating Revenue 32,755 64,689 73,633 -11.2M 130,051
Cost Of Revenue 9,879 17,048 53,135 -4.6M 35,199
Gross Profit 22,876 47,641 20,498 -5.0M 94,852
Selling General And Administration 458,601 834,696 649,551 -2.9M 1.9M
General And Administrative Expense 313,305 675,655 495,513 -1.5M 1.8M
Research And Development -- -- -- -- 0.00
Depreciation And Amortization In Income Statement 1,879 2,369 2,747 -75,293 12,610
Operating Expense 460,480 837,065 652,298 -3.0M 1.9M
Operating Income -437,604 -789,424 -631,800 -2.0M -1.8M
EBIT -591,409 -859,469 -1.4M -1.3M -1.8M
Interest Expense 0.00 0.00 4,203 -14,983 6,511
Interest Expense Non Operating 0.00 0.00 4,203 -14,983 6,511
Interest Income 3,533 15,579 14,498 23,148 17,585
Interest Income Non Operating 3,533 15,579 14,498 23,148 17,585
Net Interest Income 3,533 15,579 10,295 38,131 11,074
Other Income Expense -157,338 -85,624 -743,116 682,182 -37,140
Other Non Operating Income Expenses -53,901 -- -- -784.00 99,997
Special Income Charges -- -- -- 290,000 -50,000
Restructuring And Mergern Acquisition -- -- -- -290,000 50,000
Gain On Sale Of Security -103,437 -85,624 -743,116 392,966 -137,137
Pretax Income -591,409 -859,469 -1.4M -1.3M -1.8M
Tax Provision -- -- -- 0.00 0.00
Tax Effect Of Unusual Items 0.00 0.00 0.00 0.00 0.00
Net Income From Continuing And Discontinued Operation 600,429 -859,469 -1.4M -42,425 -2.9M
Net Income From Continuing Operation Net Minority Interest 600,429 -859,469 -1.4M -1.3M 1.8M
Net Income Including Noncontrolling Interests 600,429 -859,469 -1.4M -42,426 -2.9M
Net Income Common Stockholders 600,429 -859,469 -1.4M -42,425 -2.9M
Net Income 600,429 -859,469 -1.4M -42,425 -2.9M
EBITDA -589,530 -857,100 -1.4M -1.4M -1.7M
Normalized EBITDA -486,093 -771,476 -614,555 -2.0M -1.6M
Reconciled Depreciation 1,879 2,369 2,747 -179,508 52,610
Basic EPS -0.02 -0.02 -0.04 -- 0.10
Diluted EPS -0.02 -0.02 -0.04 -- 0.10
Basic Average Shares 37.9M 37.9M 37.9M -- 30.4M
Diluted Average Shares 37.9M 37.9M 37.9M -- 30.4M
Total Unusual Items -103,437 -85,624 -743,116 682,966 -137,137
Total Unusual Items Excluding Goodwill -103,437 -85,624 -743,116 682,966 -137,137
Tax Rate For Calcs 0.00 0.00 0.00 0.00 0.00
Normalized Income 703,866 -773,845 -621,505 -2.0M 1.9M
Depreciation Amortization Depletion Income Statement 1,879 2,369 2,747 -75,293 12,610
Depreciation Income Statement 1,879 2,369 2,747 -75,293 12,610
Diluted NI Availto Com Stockholders 600,429 -859,469 -1.4M -42,425 -2.9M
Excise Taxes -- -- -- -- 842,497
Net Income Continuous Operations 600,429 -859,469 -1.4M -1.3M 1.8M
Net Income Discontinuous Operations 0.00 0.00 0.00 1.2M -4.7M
Net Non Operating Interest Income Expense 3,533 15,579 10,295 38,131 11,074
Other Gand A 179,607 334,252 257,791 -264,468 939,137
Reconciled Cost Of Revenue 9,879 17,048 53,135 -4.6M 35,199
Salaries And Wages 133,698 341,403 237,722 -1.2M 863,279
Selling And Marketing Expense 145,296 159,041 154,038 -1.4M 60,308
Total Expenses 470,359 854,113 705,433 -7.6M 1.9M
Total Other Finance Cost -- -- -- -- --
Line Item Q3 2025Aug 31, 2025 Q2 2025May 31, 2025 Q1 2025Feb 28, 2025 Q4 2024Nov 30, 2024 Q3 2024Aug 31, 2024
Cash And Cash Equivalents 553,657 973,355 1.6M 2.3M 1.0M
Cash Cash Equivalents And Short Term Investments 553,657 973,355 1.6M 2.3M 1.0M
Accounts Receivable 13,100 18,474 89,557 91,856 1.1M
Receivables 609,316 597,606 705,487 1.2M 997,840
Inventory 276,751 291,533 58,076 80,438 1.4M
Prepaid Assets 68,659 -- -- 47,721 --
Other Current Assets -- 134,263 402,816 -- 267,602
Current Assets 1.5M 2.0M 2.8M 3.6M 3.7M
Gross PPE 23,104 36,250 529,668 529,668 2.9M
Accumulated Depreciation -22,690 -33,957 -525,006 -522,259 -2.5M
Net PPE 414.00 2,293 4,662 7,409 341,715
Goodwill -- -- -- 0.00 0.00
Goodwill And Other Intangible Assets 110,000 110,000 110,000 110,000 1.3M
Other Intangible Assets 110,000 110,000 110,000 110,000 1.3M
Investments And Advances 378,235 482,649 568,498 1.4M 731,506
Other Non Current Assets -- -- -- -- 20,798
Total Non Current Assets 488,649 594,942 683,160 1.5M 2.4M
Total Assets 2.0M 2.6M 3.5M 5.1M 6.1M
Current Debt And Capital Lease Obligation -- -- -- -- 105,392
Accounts Payable 143,216 153,416 738,213 178,874 --
Payables 143,216 153,416 738,213 178,874 --
Payables And Accrued Expenses 705,699 699,426 738,213 1.0M 2.4M
Current Accrued Expenses 562,483 546,010 -- 869,456 --
Current Deferred Revenue 2,838 5,676 6,564 12,649 11,254
Other Current Liabilities -1.00 -- -- -- --
Current Liabilities 708,536 705,102 744,777 1.1M 2.6M
Long Term Debt And Capital Lease Obligation -- -- -- 0.00 228,957
Long Term Capital Lease Obligation -- -- -- 0.00 228,957
Total Non Current Liabilities Net Minority Interest 0.00 0.00 0.00 0.00 228,957
Total Liabilities Net Minority Interest 708,536 705,102 744,777 1.1M 2.8M
Common Stock 161.4M 161.4M 161.4M 161.4M 161.2M
Capital Stock 161.4M 161.4M 161.4M 161.4M 161.2M
Additional Paid In Capital -- -- 53.0M 53.0M 53.1M
Retained Earnings -214.8M -214.2M -213.3M -211.9M -212.2M
Gains Losses Not Affecting Retained Earnings 54.7M 54.7M -183,495 -183,495 -536,890
Other Equity Adjustments 54.7M 54.7M -183,495 -183,495 -536,890
Common Stock Equity 1.3M 1.9M 2.7M 4.1M 3.3M
Stockholders Equity 1.3M 1.9M 2.7M 4.1M 3.3M
Total Equity Gross Minority Interest 1.3M 1.9M 2.7M 4.1M 3.3M
Total Capitalization 1.3M 1.9M 2.7M 4.1M 3.3M
Net Tangible Assets 1.2M 1.8M 2.6M 4.0M 2.0M
Tangible Book Value 1.2M 1.8M 2.6M 4.0M 2.0M
Working Capital 799,847 1.3M 2.0M 2.6M 1.1M
Invested Capital 1.3M 1.9M 2.7M 4.1M 3.3M
Total Debt -- -- -- 0.00 334,349
Share Issued 37.9M 37.9M 37.9M 37.9M 35.9M
Ordinary Shares Number 37.9M 37.9M 37.9M 37.9M 35.9M
Available For Sale Securities 4,310 4,310 4,310 4,310 7,635
Capital Lease Obligations -- -- -- 0.00 334,349
Current Capital Lease Obligation -- -- -- 0.00 105,392
Current Deferred Liabilities 2,838 5,676 6,564 12,649 11,254
Financial Assets Designatedas Fair Value Through Profitor Loss Total 373,925 478,339 564,188 1.4M 723,871
Finished Goods -- -- -- 0.00 871,580
Investmentin Financial Assets 378,235 482,649 568,498 1.4M 731,506
Leases 0.00 0.00 42,243 42,243 1.1M
Loans Receivable 520,937 520,937 612,677 1.1M --
Machinery Furniture Equipment 23,104 36,250 487,425 487,425 1.2M
Non Current Deferred Assets -- -- -- 0.00 0.00
Non Current Deferred Taxes Assets -- -- -- 0.00 0.00
Non Current Prepaid Assets -- -- -- 0.00 --
Other Equity Interest -- -- 1.8M 1.8M 1.7M
Other Inventories 25,926 11,728 11,727 11,728 245,772
Other Properties -- -- -- -- 535,374
Other Receivables 3,249 3,249 3,250 3,249 23,411
Properties 0.00 0.00 0.00 0.00 0.00
Raw Materials 250,825 279,805 46,349 68,710 291,767
Taxes Receivable 72,030 54,946 3.00 3.00 -117,567
Line Item Q3 2025Aug 31, 2025 Q2 2025May 31, 2025 Q1 2025Feb 28, 2025 Q4 2024Nov 30, 2024 Q3 2024Aug 31, 2024
Operating Cash Flow -418,721 -778,104 -1.3M -586,494 -1.1M
Cash Flow From Continuing Operating Activities -418,721 -778,103 -1.3M -8.0M 6.1M
Depreciation And Amortization 1,879 2,369 2,747 -179,508 52,610
Depreciation Amortization Depletion 1,879 2,369 2,747 -179,508 52,610
Stock Based Compensation 2,328 38,199 0.00 -490,498 550,909
Deferred Tax -- -- -- 0.00 1,439
Deferred Income Tax -- -- -- 0.00 1,439
Change In Working Capital 72,110 3,301 -649,336 -6.7M 4.7M
Change In Receivables -11,710 7,880 -401.00 -1.7M 2.2M
Change In Inventory 14,782 -233,457 22,362 -5.2M 3.3M
Change In Payables And Accrued Expense 6,272 -38,787 -310,117 -87,554 -708,261
Change In Other Working Capital -2,838 -888.00 -6,085 305,682 -236,037
Other Non Cash Items -- -- 1.00 4.4M -4.5M
Capital Expenditure -- -- -- -- --
Purchase Of PPE -- -- -- 0.00 2,769
Net PPE Purchase And Sale -- -- -- 0.00 2,769
Sale Of Business 0.00 48,127 73,353 -- 0.00
Sale Of Investment -- -- -- -- 0.00
Net Investment Purchase And Sale -- -- -- -- 0.00
Investing Cash Flow 0.00 148,127 523,353 1.9M 0.00
Cash Flow From Continuing Investing Activities 0.00 148,127 523,353 1.9M 0.00
Repayment Of Debt -- -- -- -- 29,130
Net Issuance Payments Of Debt -- -- -- 191,072 29,130
Issuance Of Capital Stock -- -- -- 0.00 0.00
Net Common Stock Issuance -- -- -- 0.00 0.00
Financing Cash Flow 0.00 0.00 0.00 2,989 29,130
Cash Flow From Continuing Financing Activities -- -- 0.00 191,072 29,130
Effect Of Exchange Rate Changes -977.00 227.00 5,826 17,001 7,742
Changes In Cash -418,721 -629,977 -744,741 1.3M -1.1M
Beginning Cash Position 973,355 1.6M 2.3M 1.0M 2.1M
End Cash Position 553,657 973,355 1.6M 2.3M 1.0M
Free Cash Flow -418,721 -778,104 -1.3M -586,494 -1.1M
Cash From Discontinued Financing Activities 0.00 0.00 0.00 -- 29,130
Cash From Discontinued Investing Activities 0.00 0.00 0.00 -- 0.00
Cash From Discontinued Operating Activities 0.00 0.00 0.00 7.4M -6.6M
Change In Prepaid Assets 65,604 268,553 -355,095 -21,968 115,098
Common Stock Issuance -- -- -- 0.00 0.00
Depreciation 1,879 2,369 2,747 -179,508 52,610
Gain Loss On Investment Securities -- -- 48,128 -- --
Long Term Debt Payments -- -- -- -- 29,130
Net Business Purchase And Sale 0.00 48,127 73,353 -- 0.00
Net Foreign Currency Exchange Gain Loss 977.00 -225.00 -5,828 27,946 34,689
Net Income From Continuing Operations -600,429 -859,469 -1.4M -2.7M 624,311
Net Long Term Debt Issuance -- -- -- 191,072 29,130
Net Other Investing Changes 0.00 100,000 450,000 -- --
Operating Gains Losses 977.00 -48,353 42,300 -- 34,689
Proceeds From Stock Option Exercised -- -- -- 0.00 0.00
Unrealized Gain Loss On Investment Securities 104,414 85,850 700,815 -428,659 102,448
NEWS
Loading news...
TRENDING
Loading...